Endometrial cancer: a review and current management strategies: part I.
about
Treatment of Early Stage Endometrial Cancer by Transumbilical Laparoendoscopic Single-Site Surgery Versus Traditional Laparoscopic Surgery: A Comparison Study.Molecular cues on obesity signals, tumor markers and endometrial cancer.Antiprogestins in gynecological diseases.Role of Numb expression and nuclear translocation in endometrial cancer.Multivariate Analysis of Prognostic Biomarkers in Surgically Treated Endometrial Cancer.Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival.Transvaginal/transrectal ultrasound for assessing myometrial invasion in endometrial cancer: a comparison of six different approaches.Comparison of dynamic contrast-enhanced magnetic resonance imaging with T2-weighted imaging for preoperative staging of early endometrial carcinomaThe effect of visceral obesity on clinicopathological features in patients with endometrial cancer: a retrospective analysis of 200 Chinese patients.Role of MicroRNAs in carcinogenesis that potential for biomarker of endometrial cancerAre preoperative histology and MRI useful for classification of endometrial cancer risk?Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis.Clinical Benefits Associated With Medicaid Coverage Before Diagnosis of Gynecologic Cancers.Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells.Dietary fat intake and endometrial cancer risk: A dose response meta-analysisUnderstanding Molecular Landscape of Endometrial Cancer through Next Generation Sequencing: What We Have Learned so Far?Proliferation and metastatic potential of endometrial cancer cells in response to metformin treatment in a high versus normal glucose environment.The sL1CAM in sera of patients with endometrial and ovarian cancers.Incidence of positive peritoneal cytology in patients with endometrial carcinoma after hysteroscopy vs. dilatation and curettage.Sentinel Lymph Node Mapping in Patients with Endometrial Carcinoma: Less Can Be More.Clinical translation for endometrial cancer stem cells hypothesis.Implementation of health risk assessments with family health history: barriers and benefits.Enhanced recovery programme in robotic hysterectomy.GnRH and GnRH receptors in the pathophysiology of the human female reproductive system.The clinical management of inoperable endometrial carcinoma.Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences.Endometrial Cancer Trends by Race and Histology in the USA: Projecting the Number of New Cases from 2015 to 2040.Endometrioid endometrial adenocarcinoma: an increase of G3 cancers?Putative tumor suppression function of SIRT6 in endometrial cancer.Management and Survival of Elderly and Very Elderly Patients with Endometrial Cancer: An Age-Stratified Study of 1228 Women from the FRANCOGYN Group.Referral patterns between high- and low-volume centers and associations with uterine cancer treatment and survival: a population-based study of Medicare, Medicaid, and privately insured women.Transvaginal/transrectal ultrasound for preoperative identification of high-risk cases in well- or moderately differentiated endometrioid carcinoma.Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancerDownregulation of endometrial mesenchymal marker SUSD2 causes cell senescence and cell death in endometrial carcinoma cellsPterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer.SOX15 regulates proliferation and migration of endometrial cancer cellsTransvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial infiltration in patients with endometrial cancer: a systematic review and meta-analysis.Abnormal mismatch repair and other clinicopathologic predictors of poor response to progestin treatment in young women with endometrial complex atypical hyperplasia and well-differentiated endometrial adenocarcinoma: a consecutive case series.Intraoperative Pathologic Consultation on Hysterectomy Specimens for Endometrial Cancer: An Assessment of the Accuracy of Frozen Sections, "Gross-Only" Evaluations, and Obtaining Random Sections of a Grossly "Normal" Endometrium.FKBP51 decreases cell proliferation and increases progestin sensitivity of human endometrial adenocarcinomas by inhibiting Akt.
P2860
Q27315141-24792B36-89BB-4202-A197-979B26D13C0CQ30372789-F81E0033-3292-41F7-ABE1-B6BB25E5C2D9Q34587636-9B4724AD-860C-42B4-B8D3-8BCF8574BBD7Q35167565-36F6C33F-1061-49D9-9461-5F8D6455C1F0Q35672819-4BBB432F-28D8-448D-890D-5CF4306E5215Q35863154-056A1250-2F58-451B-800F-201C7A897151Q35876943-C75A3349-8FC7-4BC6-8C54-5061A8D11170Q35887472-8DCC51FA-5F72-4822-8A5C-90F9516D08FEQ35954346-8E4578A6-4663-48CC-84CA-1D9E58C919C5Q35967172-378070D7-C4A7-4B3B-8210-B6D495EE6B7AQ36080667-D85C3D98-0B42-4C19-88F1-C9C48737FDFDQ36416307-B1E01817-FDD5-45F3-AC92-761EA417DFD1Q37117898-8A63AD60-B56E-4DC3-80D6-F1405CFE7B1FQ37287535-1FFFA019-40BA-44BF-A97F-0ED5E5E020ADQ37328112-5575DED5-8180-41E0-A256-FE2C10601A45Q37382351-EBB0F8F5-5A59-4071-8727-21BF7BD1F94CQ37407105-FEA71677-506B-49C9-BF2F-1E1258B80681Q37578356-950D4ECB-3FD7-4F16-B97E-7889DEC3A9D8Q37671453-115B2AED-A9FF-4750-95E4-AB91B1C408F6Q38431386-0C509584-E6A0-44AA-BC27-3D68605C72A0Q38557171-D6C9ECD3-7308-418B-9DB7-8D801D625756Q38565582-A2448CC2-38A7-4584-A89C-EFA24875F95EQ38583986-D0B3404F-E5B2-493C-B698-F6C022B3E3BBQ38682630-B61137B1-48A7-45D6-B962-6266383B077CQ38783340-9DF65B67-B37F-4731-A76D-07F5FCD8A67FQ38788210-C18F15DD-C8B6-4965-8B74-BDBF4AF82252Q38810122-2C5881C6-B6E4-46F6-957A-CF13BFFFB268Q38831227-B58B8D51-E2EF-46D9-BAD3-54AD7CCBA368Q38852078-52878F39-9B41-45F7-8508-EF9A0621239DQ39069570-F5FB8E72-E046-402E-82F9-58A0D77D78F4Q39808566-7F6990F7-30F7-40AE-A860-123E5364FB7BQ40879791-176404A9-2C22-48C0-8599-28418FBE8688Q41099951-F2A0BCCD-82DE-4085-B27D-7DC2B300E423Q41523091-A60EE4C3-7053-44D7-87E1-0B59682489E7Q42371820-D06BFC53-77A0-46A0-B526-D4B9F0627DDEQ42379103-15354ED8-C918-48E4-BB6B-E4919ADC0478Q42700296-2035AEE2-FAF3-40D4-A13B-D48556007CF2Q46445529-4B3C9E89-A82F-4751-9DDE-8B35DD6025E9Q46785812-270EC870-325E-4C22-80EF-57773003A9EDQ47112399-693CAF78-6557-4DD5-8657-59830A39EC99
P2860
Endometrial cancer: a review and current management strategies: part I.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Endometrial cancer: a review and current management strategies: part I.
@ast
Endometrial cancer: a review and current management strategies: part I.
@en
Endometrial cancer: a review and current management strategies: part I.
@nl
type
label
Endometrial cancer: a review and current management strategies: part I.
@ast
Endometrial cancer: a review and current management strategies: part I.
@en
Endometrial cancer: a review and current management strategies: part I.
@nl
prefLabel
Endometrial cancer: a review and current management strategies: part I.
@ast
Endometrial cancer: a review and current management strategies: part I.
@en
Endometrial cancer: a review and current management strategies: part I.
@nl
P2093
P1433
P1476
Endometrial cancer: a review and current management strategies: part I.
@en
P2093
Alexander B Olawaiye
Dave Boruta
Emery Salom
Fadi Abu Shahin
Jeannine Villella
Mario Leitao
Molly Brewer
Paola Gehrig
SGO Clinical Practice Endometrial Cancer Working Group
P304
P356
10.1016/J.YGYNO.2014.05.018
P407
P577
2014-06-04T00:00:00Z